Clinical Trials List
2022-04-01 - 2029-10-31
Phase III
Not yet recruiting3
Recruiting1
ICD-10C90.00
Multiple myeloma not having achieved remission
ICD-10C90.02
Multiple myeloma in relapse
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9203.00
Multiple myeloma, without mention of remission
-
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/15
Investigators and Locations
Co-Principal Investigator
- Che-Hung Lin 未分科
- Chen-Yuan Lin 未分科
- Ching-Chan Lin 無
- Ming-Hung Tsai 未分科
- Ming-Yu Lien 無
- Chi-Ching Chen 無
- Tzu-Ting Chen 無
- 鄭富銘 無
- 王秀慈 未分科
- 王幸婷 Division of Hematology & Oncology
- 陳珈妤 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Po-Nan Wang 未分科
- Tung-Liang Lin 無
- Ming-Chung Kao 無
- 林潔 無
- HSUAN JEN SHIH
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
760 participants
